VAERS Explorer
Back to explore

Report #2902932

Received Jul 8, 2026

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Male
Age
11 yrs
State
KY
Recovered
Unknown
Vaccinated
Jun 10, 2026
Onset
Jun 10, 2026
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
DTAPHEPBIPDTAP + HEPB + IPV (PEDIARIX)GLAXOSMITHKLINE BIOLOGICALSUNK3C423—

Symptoms (1)

Product administered to patient of inappropriate age

Symptom narrative

Pediarix administration to an 11-year-old patient; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of inappropriate age at vaccine administration in a 11-year-old male patient who received DTPa-HBV-IPV (Pediarix) suspension for injection in pre-filled syringe (batch number 3C423 with expiry date 06-SEP-2027) for prophylaxis. On 10-JUN-2026, the patient received Pediarix. On 10-JUN-2026, an unknown time after receiving Pediarix, the patient experienced inappropriate age at vaccine administration (Verbatim: Pediarix administration to an 11-year-old patient). The outcome of the inappropriate age at vaccine administration was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.